Delivery Order SPE2DB22D2007-SPE2DB25FJ4HE
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count units) with a ceiling value of $3,511.93. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Candesartan Cilexetil 32 mg tablets (90-count units) with a ceiling value of $59,408.56. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a non-competitive set-aside contract and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a $14,923.44 delivery order to AmerisourceBergen Drug Corp for Candesartan Cilexetil 32 mg tablets (90-count units) on July 25, 2025, with completion scheduled for July 28, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and...
- The Defense Logistics Agency awarded a delivery order valued at $15,002.49 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count units). This competitively awarded, non-set-aside contract employs firm fixed-price pricing and was executed on August 7, 2025, with an ultimate completion date of August 8, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,485.26 to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count bottles) under a firm fixed-price contract. This competitively awarded delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a single transaction within DLA's pharmaceutical supply chain operations. The contract involves no set-aside designation and is being performed at...
- The Defense Logistics Agency awarded a delivery order valued at $4,529.28 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Candesartan Cilexetil 32 mg tablets in quantities of 90. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 19, 2025, and carries no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Candesartan Cilexetil 4 mg tablets (90-count units) with a ceiling value of $2,812.08. This is a firm fixed-price delivery order with an ultimate completion date of August 25, 2025, and was competitively awarded without set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $40,296.55 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Candesartan Cilexetil 32 mg, with an ultimate completion date of August 5, 2025. This is a firm fixed-price, non-set-aside contract executed under a competitive procurement process. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location in the same city. The delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Candesartan Cilexetil 16 mg tablets in a quantity of 90 units, with a ceiling value of $13,581.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 24,...
- The Defense Logistics Agency awarded a $1,506.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 16 mg tablets (90-count bottles). Awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, this contract represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and serves as...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ4HEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Candesartan Cilexetil 32 mg tablets (90-count bottles) under a firm fixed-price contract valued at $38,032.56. The award was issued on August 25, 2025, with an ultimate completion date of August 26, 2025. This delivery order represents a non-competitive, non-set-aside award to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent contract serves as a prime vendor agreement enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military and federal healthcare systems worldwide. Through this vehicle, the company provides critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains to customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.0k | 8/25/25 |